U.S. Device Firm Reverses Trend, Ends Outsourcing To China, Taiwan
This article was originally published in PharmAsia News
In a reversal of the trend, a North Carolina medical device maker is bringing home its Asian production work that has been performed in China and Taiwan. Diagnostics Devices said the move is to take place within two years, adding 100 jobs at a U.S. facility. Plants in China and Taiwan have been producing the company's Prodigy Meter. The head of Diagnostics Devices said high-tech manufacturing processes were making it possible for the company to produce its products at a lower cost in the United States with a smaller work force and elimination of shipping costs. (Click here for more
You may also be interested in...
Demand for tele-diagnostic tools has reached unprecedented levels during COVID-19, said Kees Wesdrop, Royal Philips’ chief business leader of precision diagnosis.
Transparency On COVID Vaccine Clinical Holds Needed, Sharfstein Says; US FDA Advisory Cmtes Offer Venue
Former acting Commissioner Josh Sharfstein argues that while agency officials have done a commendable job in overall communication on COVID vaccine development, more information is needed on the clinical holds.
Trump administration effort to reduce drug prices by curtailing agency program requiring new approvals for some old products undermines FDA’s role in policing the safety of prescription drugs, experts say.